Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 1 1

Status

Completed 24Recruiting 10Active not recruiting 6Withdrawn 2Terminated 1Not yet recruiting 1

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 3Gynecologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 82Breast Neoplasms 38Lung Neoplasms 26Triple Negative Breast Neoplasms 25Ovarian Neoplasms 20Squamous Cell Carcinoma of Head and Neck 19Fallopian Tube Neoplasms 16Small Cell Lung Carcinoma 15Neoplasm Metastasis 13Esophageal Neoplasms 12Endometrial Neoplasms 12Prostatic Neoplasms 9Neoplasms 9Head and Neck Neoplasms 8Colorectal Neoplasms 8Carcinoma 8Urinary Bladder Neoplasms 7Uterine Cervical Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Oropharyngeal Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Pancreatic Neoplasms 5Melanoma 5Laryngeal Neoplasms 5Carcinoma, Transitional Cell 5Stomach Neoplasms 4Mouth Neoplasms 4Carcinoma, Squamous Cell 4Carcinoma, Ovarian Epithelial 4Urothelial Cancer 3

Interventions

pembrolizumab 35Cisplatin 12Paclitaxel 9lenvatinib 7Carboplatin 6belzutifan 5Saline Solution 4Pemetrexed 4Oxaliplatin 4Fluorouracil 4Leucovorin 3Etoposide 3Docetaxel 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3olaparib 2enfortumab vedotin 2durvalumab 2Surgical Procedures, Operative 2Radiotherapy 2Levoleucovorin 2Glucose 2Capecitabine 2Bevacizumab 2zanidatamab 1tislelizumab 1sacituzumab govitecan 1liposomal doxorubicin 1enzalutamide 1balstilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × Parkinson Disease 4, Autosomal Dominant Lewy Body × Carboplatin × Clear all
NCT04380636 2026-05-15

MK-7339-012

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
870 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05173987 2026-05-05

KEYNOTE-C93

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
280 enrolled
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT05017012 2026-03-27

MK-3475A-C18

Merck Sharp & Dohme LLC

Phase 1 Active not recruiting
72 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT05298423 2025-08-01

KEYVIBE-006

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
611 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT04634877 2025-06-09

KEYNOTE-B21

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
990 enrolled
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT04956692 2024-12-03

MK-3475-A86

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
531 enrolled 18 charts
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡